Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amgen Inc. stock logo
AMGN
Amgen
$269.98
+0.2%
$275.10
$211.71
$329.72
$144.81B0.582.82 million shs2.44 million shs
Alphabet Inc. stock logo
GOOGL
Alphabet
$171.95
+10.2%
$147.85
$103.54
$174.71
$1.94T1.0525.80 million shs64.64 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amgen Inc. stock logo
AMGN
Amgen
+0.22%+0.39%-5.70%-13.40%+13.06%
Alphabet Inc. stock logo
GOOGL
Alphabet
+10.22%+11.59%+13.97%+12.99%+65.80%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amgen Inc. stock logo
AMGN
Amgen
4.7123 of 5 stars
2.34.04.23.91.91.72.5
Alphabet Inc. stock logo
GOOGL
Alphabet
2.6427 of 5 stars
2.43.00.00.02.61.72.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amgen Inc. stock logo
AMGN
Amgen
2.53
Moderate Buy$296.959.99% Upside
Alphabet Inc. stock logo
GOOGL
Alphabet
2.89
Moderate Buy$187.829.23% Upside

Current Analyst Ratings

Latest GOOGL and AMGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$185.00 ➝ $205.00
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$185.00 ➝ $215.00
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$164.00 ➝ $202.00
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$170.00 ➝ $200.00
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$160.00 ➝ $200.00
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$170.00 ➝ $190.00
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$155.00 ➝ $200.00
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$180.00 ➝ $200.00
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$165.00 ➝ $200.00
4/26/2024
Alphabet Inc. stock logo
GOOGL
Alphabet
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$160.00 ➝ $200.00
4/17/2024
Amgen Inc. stock logo
AMGN
Amgen
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$314.00 ➝ $284.00
(Data available from 4/27/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amgen Inc. stock logo
AMGN
Amgen
$28.19B5.14$26.06 per share10.36$11.65 per share23.17
Alphabet Inc. stock logo
GOOGL
Alphabet
$307.39B6.95$7.60 per share22.62$22.79 per share7.54

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amgen Inc. stock logo
AMGN
Amgen
$6.72B$12.4921.6212.872.5423.83%154.27%10.95%5/2/2024 (Confirmed)
Alphabet Inc. stock logo
GOOGL
Alphabet
$73.80B$6.5226.3722.101.4325.90%30.01%20.91%7/23/2024 (Estimated)

Latest GOOGL and AMGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Amgen Inc. stock logo
AMGN
Amgen
$3.82N/A-$3.82N/AN/AN/A  
2/6/2024Q4 23
Amgen Inc. stock logo
AMGN
Amgen
$4.66$4.71+$0.05$8.00$8.13 billion$8.20 billion    
1/30/2024Q4 23
Alphabet Inc. stock logo
GOOGL
Alphabet
$1.60$1.64+$0.04$1.64$70.77 billion$86.31 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amgen Inc. stock logo
AMGN
Amgen
$9.003.33%+10.01%72.06%12 Years
Alphabet Inc. stock logo
GOOGL
Alphabet
N/AN/AN/AN/AN/A

Latest GOOGL and AMGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/6/2024
Amgen Inc. stock logo
AMGN
Amgen
quarterly$2.253.25%5/16/20245/17/20246/7/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amgen Inc. stock logo
AMGN
Amgen
10.14
1.65
1.13
Alphabet Inc. stock logo
GOOGL
Alphabet
0.05
2.10
2.10

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Amgen Inc. stock logo
AMGN
Amgen
76.50%
Alphabet Inc. stock logo
GOOGL
Alphabet
40.03%

Insider Ownership

CompanyInsider Ownership
Amgen Inc. stock logo
AMGN
Amgen
0.46%
Alphabet Inc. stock logo
GOOGL
Alphabet
0.88%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Amgen Inc. stock logo
AMGN
Amgen
26,700536.38 million533.91 millionOptionable
Alphabet Inc. stock logo
GOOGL
Alphabet
182,50212.43 billion12.32 billionOptionable

GOOGL and AMGN Headlines

SourceHeadline
Workers accuse Google of ‘tantrum after 50 fired over Israel contract protestWorkers accuse Google of ‘tantrum' after 50 fired over Israel contract protest
theguardian.com - April 27 at 7:00 AM
MarketBeat Week in Review – 4/22 - 4/26 (GOOGL)MarketBeat Week in Review – 4/22 - 4/26 (GOOGL)
marketbeat.com - April 27 at 7:00 AM
John L. Hennessy Sells 2,100 Shares of Alphabet Inc. (NASDAQ:GOOGL) StockJohn L. Hennessy Sells 2,100 Shares of Alphabet Inc. (NASDAQ:GOOGL) Stock
insidertrades.com - April 27 at 6:57 AM
This Is the Only FAANG Stock Lawmakers on Capitol Hill Were Net Buyers of Last YearThis Is the Only FAANG Stock Lawmakers on Capitol Hill Were Net Buyers of Last Year
fool.com - April 27 at 6:17 AM
BHP, Anglo American, Meta, Google, Microsoft, AstraZeneca, Rubrik, ComCast and more - Markets DefusedBHP, Anglo American, Meta, Google, Microsoft, AstraZeneca, Rubrik, ComCast and more - Markets Defused
proactiveinvestors.co.uk - April 27 at 6:03 AM
HTLF Bank Invests $12.84 Million in Alphabet Inc. (NASDAQ:GOOGL)HTLF Bank Invests $12.84 Million in Alphabet Inc. (NASDAQ:GOOGL)
marketbeat.com - April 27 at 5:23 AM
Alphabet Target of Unusually Large Options Trading (NASDAQ:GOOGL)Alphabet Target of Unusually Large Options Trading (NASDAQ:GOOGL)
americanbankingnews.com - April 27 at 4:54 AM
3 Cheap Tech Stocks to Buy Now3 Cheap Tech Stocks to Buy Now
fool.com - April 27 at 4:45 AM
What Risk Factors Investors Should Note in Alphabet Inc (GOOGL) Quarterly ReportWhat Risk Factors Investors Should Note in Alphabet Inc (GOOGL) Quarterly Report
americanbankingnews.com - April 27 at 4:06 AM
3 Top Artificial Intelligence (AI) Stocks That Billionaires Jim Simons, Ray Dalio, and Israel Englander Are Buying3 Top Artificial Intelligence (AI) Stocks That Billionaires Jim Simons, Ray Dalio, and Israel Englander Are Buying
fool.com - April 27 at 3:05 AM
Alphabet (NASDAQ:GOOGL) Trading Up 9.6% After Analyst UpgradeAlphabet (NASDAQ:GOOGL) Trading Up 9.6% After Analyst Upgrade
americanbankingnews.com - April 27 at 2:44 AM
Alphabet (NASDAQ:GOOGL) Hits New 1-Year High on Analyst UpgradeAlphabet (NASDAQ:GOOGL) Hits New 1-Year High on Analyst Upgrade
americanbankingnews.com - April 27 at 1:42 AM
Alphabet Sees Unusually High Options Volume (NASDAQ:GOOGL)Alphabet Sees Unusually High Options Volume (NASDAQ:GOOGL)
marketbeat.com - April 26 at 10:50 PM
Google parent Alphabet soars past $2 trillion market cap on AI strengthGoogle parent Alphabet soars past $2 trillion market cap on AI strength
livemint.com - April 26 at 10:44 PM
Alphabet And Microsoft Beat Targets, Stock Prices Pop 12% And 4%Alphabet And Microsoft Beat Targets, Stock Prices Pop 12% And 4%
forbes.com - April 26 at 10:44 PM
Alphabet Heads to a $2T Market Cap for the First Time. The Google Parent Could Overtake Nvidia.Alphabet Heads to a $2T Market Cap for the First Time. The Google Parent Could Overtake Nvidia.
msn.com - April 26 at 10:44 PM
Insider Selling: Alphabet Inc. (NASDAQ:GOOGL) Director Sells 2,100 Shares of StockInsider Selling: Alphabet Inc. (NASDAQ:GOOGL) Director Sells 2,100 Shares of Stock
marketbeat.com - April 26 at 7:59 PM
Does Mag 7 Leadership Remain Intact Post-Tesla and Meta Disappointments?Does Mag 7 Leadership Remain Intact Post-Tesla and Meta Disappointments?
zacks.com - April 26 at 7:26 PM
Time to Buy the Surge in Alphabets (GOOGL) Stock After Earnings?Time to Buy the Surge in Alphabet's (GOOGL) Stock After Earnings?
zacks.com - April 26 at 7:06 PM
Google plans $3 bln data center investment in Indiana, VirginiaGoogle plans $3 bln data center investment in Indiana, Virginia
reuters.com - April 26 at 5:48 PM
Alphabet Execs Call YouTube Shorts a ‘Long-Term Bet for the Business’Alphabet Execs Call YouTube Shorts a ‘Long-Term Bet for the Business’
observer.com - April 26 at 5:43 PM
Alphabet Beats Revenue Estimates as AI Fuels Cloud GrowthAlphabet Beats Revenue Estimates as AI Fuels Cloud Growth
finance.yahoo.com - April 26 at 5:43 PM
Google parent announces first-ever dividend; beats on sales, profit; shares soarGoogle parent announces first-ever dividend; beats on sales, profit; shares soar
msn.com - April 26 at 5:43 PM
Stock Market Today: Dow ends higher, S&P 500 posts biggest weekly gain since NovemberStock Market Today: Dow ends higher, S&P 500 posts biggest weekly gain since November
marketwatch.com - April 26 at 5:43 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Amgen logo

Amgen

NASDAQ:AMGN
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Alphabet logo

Alphabet

NASDAQ:GOOGL
Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube. It is also involved in the sale of apps and in-app purchases and digital content in the Google Play and YouTube; and devices, as well as in the provision of YouTube consumer subscription services. The Google Cloud segment offers infrastructure, cybersecurity, databases, analytics, AI, and other services; Google Workspace that include cloud-based communication and collaboration tools for enterprises, such as Gmail, Docs, Drive, Calendar, and Meet; and other services for enterprise customers. The Other Bets segment sells healthcare-related and internet services. The company was incorporated in 1998 and is headquartered in Mountain View, California.